FDA rejects emergency use approval for Bharat Biotech’s vaccine

FDA rejects emergency use approval for Bharat Biotech’s vaccine

0

FDA rejects emergency use approval for Bharat Biotech’s vaccine

0
0



India on Friday reported 91,702 new coronavirus cases over the last 24 hours, taking its overall caseload to 2,92,74,823 since the pandemic broke out in January 2020. For the fourth consecutive day, the country recorded less than 1 lakh cases. Deaths rose by 3,403 to 3,63,079.

The United States Food and Drug Administration has rejected Bharat Biotech’s proposal for emergency use authorisation of its coronavirus vaccine in the country. Ocugen Inc, the company co-developing Covaxin for the US market, says it would now aim to file for a full approval of the shot.

Globally, the coronavirus disease has infected over 17.40 crore people and killed more than 37.49 lakh since the pandemic broke out in December 2019, according to Johns Hopkins University.

The national helpline number is 011-23978046, and the toll-free number is 1075.

These are the helpline numbers for the states and Union Territories.

LEAVE YOUR COMMENT

Your email address will not be published. Required fields are marked *